As previously reported, Leerink downgraded Humana (HUM) to Market Perform from Outperform with a price target of $250, down from $400. Given the just-disclosed Stars headwinds for 2026, “the lack
As previously reported, Leerink downgraded Humana (HUM) to Market Perform from Outperform with a price target of $250, down from $400. Given the just-disclosed Stars headwinds for 2026, “the lack
Leerink downgraded Humana to Market Perform from Outperform with a price target of $250, down from $400. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial
Leerink הורידו את הדירוג שלהם עבור Humana מ-“קנייה” ל-“דירוג החזקה” וגם הורידו את מחיר היעד עבור החברה מ-400$ ל-250$.
מחיר המניה של Humana ירד ב-21.6%, כלומר הוא ירד ב-60.44 דולר, דבר שהביא למחיר חדש של 219.01 דולר.
Humana is down -21.6%, or -$60.44 to $219.01. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by